Exact Sciences Corp. Files Q1 2025 10-Q

Ticker: EXAS · Form: 10-Q · Filed: May 1, 2025 · CIK: 1124140

Exact Sciences CORP 10-Q Filing Summary
FieldDetail
CompanyExact Sciences CORP (EXAS)
Form Type10-Q
Filed DateMay 1, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, healthcare

Related Tickers: EXAS

TL;DR

EXAS Q1 2025 10-Q filed. Financials updated.

AI Summary

Exact Sciences Corp. reported its first quarter 2025 results, ending March 31, 2025. The company's filing details its financial position and operational performance for the period. Specific financial figures and operational metrics are provided within the report.

Why It Matters

This filing provides investors and analysts with the latest financial performance data for Exact Sciences Corp., crucial for understanding the company's current health and future prospects.

Risk Assessment

Risk Level: medium — The company operates in the highly competitive and regulated healthcare sector, facing risks related to product development, market adoption, and reimbursement.

Key Numbers

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.

When was this 10-Q filed with the SEC?

This 10-Q was filed with the SEC on May 1, 2025.

What is the company's principal executive office location?

The company's principal executive office is located at 5505 Endeavor Lane, Madison, WI.

What is the Standard Industrial Classification (SIC) code for Exact Sciences Corp.?

The SIC code for Exact Sciences Corp. is 8071, which falls under SERVICES-MEDICAL LABORATORIES.

What fiscal year end does Exact Sciences Corp. observe?

Exact Sciences Corp. observes a fiscal year end on December 31.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding EXACT SCIENCES CORP (EXAS).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing